News
MindImmune Receives ADDF Backing to Support First-in-Human Trials
RightHill Ventures portfolio company MindImmune has received $5m in backing from the Alzheimer’s Drug Discovery
Adept Materials Launches Lilypad™, Advancing Passive Moisture Control in Buildings
Providence, R.I. — 2.12.2026 — RightHill Ventures portfolio company Adept Materials has launched Lilypad™, a
MindImmune Appoints Industry Leaders to Board of Directors
Brad Margus and Robert Michael Poole, MD FACP, bring deep background and experience. Mr. Margus
VoltServer secures $17.5M in Series B Funding
Innovative Energy Company VoltServer secures venture capital funding EAST GREENWICH, RI / ACCESSWIRE / April
State of Innovation: R.I.’s ecosystem for entrepreneurs shows resilience
For the developers of Pointz, a navigation app geared toward safer routes for cyclists, Rhode
RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company
New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment